articleTop 1% cited

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

AIDS · 2002 · Vol. 16(7) · pp. 1051–1058

Robert S. Hogg✉(AIDS Vancouver)Katherine Heath(University of British Columbia)David R. Bangsberg(San Francisco General Hospital)Benita Yip(AIDS Vancouver)Natasha Press(AIDS Vancouver)Michael V. O’Shaughnessy(AIDS Vancouver)Julio Montaner(University of British Columbia)

View via DOI Publisher page

Abstract

Our study demonstrates that even after adjusting for other prognostic factors intermittent use of antiretroviral therapy was associated with increased mortality.

HIV/AIDS Research and Interventions HIV/AIDS drug development and treatment HIV Research and TreatmentMedicineConfidence intervalInternal medicinePopulationAntiretroviral therapyMultivariate analysisUnivariate analysisPharmacotherapySurgeryHuman immunodeficiency virus (HIV)

MeSH terms

AdolescentAdultBritish ColumbiaCause of DeathData CollectionDrug Administration ScheduleFemaleFollow-Up StudiesHumansMaleMiddle AgedPatient CompliancePrognosisProspective StudiesRisk

Citations

427

FWCI

12.17

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders